SEQUENCE LISTING

<110>  Rigshospitalet, Region Hovedstaden
 
<120>  Classification of individuals suffering from cardiovascular 
       diseases according to survival prognoses as found by measuring 
       the levels of biomarker YKL-40

<130>  P1808PC00

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  1741
<212>  DNA
<213>  Homo sapiens

<400>  1
ctaggtagct ggcaccagga gccgtgggca agggaagagg ccacaccctg ccctgctctg       60

ctgcagccag aatgggtgtg aaggcgtctc aaacaggctt tgtggtcctg gtgctgctcc      120

agtgctgctc tgcatacaaa ctggtctgct actacaccag ctggtcccag taccgggaag      180

gcgatgggag ctgcttccca gatgcccttg accgcttcct ctgtacccac atcatctaca      240

gctttgccaa tataagcaac gatcacatcg acacctggga gtggaatgat gtgacgctct      300

acggcatgct caacacactc aagaacagga accccaacct gaagactctc ttgtctgtcg      360

gaggatggaa ctttgggtct caaagatttt ccaagatagc ctccaacacc cagagtcgcc      420

ggactttcat caagtcagta ccgccattcc tgcgcaccca tggctttgat gggctggacc      480

ttgcctggct ctaccctgga cggagagaca aacagcattt taccacccta atcaaggaaa      540

tgaaggccga atttataaag gaagcccagc cagggaaaaa gcagctcctg ctcagcgcag      600

cactgtctgc ggggaaggtc accattgaca gcagctatga cattgccaag atatcccaac      660

acctggattt cattagcatc atgacctacg attttcatgg agcctggcgt gggaccacag      720

gccatcacag tcccctgttc cgaggtcagg aggatgcaag tcctgacaga ttcagcaaca      780

ctgactatgc tgtggggtac atgttgaggc tgggggctcc tgccagtaag ctggtgatgg      840

gcatccccac cttcgggagg agcttcactc tggcttcttc tgagactggt gttggagccc      900

caatctcagg accgggaatt ccaggccggt tcaccaagga ggcagggacc cttgcctact      960

atgagatctg tgacttcctc cgcggagcca cagtccatag aaccctcggc cagcaggtcc     1020

cctatgccac caagggcaac cagtgggtag gatacgacga ccaggaaagc gtcaaaagca     1080

aggtgcagta cctgaaggat aggcagctgg caggcgccat ggtatgggcc ctggacctgg     1140

atgacttcca gggctccttc tgcggccagg atctgcgctt ccctctcacc aatgccatca     1200

aggatgcact cgctgcaacg tagccctctg ttctgcacac agcacggggg ccaaggatgc     1260

cccgtccccc tctggctcca gctggccggg agcctgatca cctgccctgc tgagtcccag     1320

gctgagcctc agtctccctc ccttggggcc tatgcagagg tccacaacac acagatttga     1380

gctcagccct ggtgggcaga gaggtaggga tggggctgtg gggatagtga ggcatcgcaa     1440

tgtaagactc gggattagta cacacttgtt gatgattaat ggaaatgttt acagatcccc     1500

aagcctggca agggaatttc ttcaactccc tgccccctag ccctccttat caaaggacac     1560

cattttggca agctctatca ccaaggagcc aaacatccta caagacacag tgaccatact     1620

aattataccc cctgcaaagc cagcttgaaa ccttcactta ggaacgtaat cgtgtcccct     1680

atcctacttc cccttcctaa ttccacagct gctcaataaa gtacaagagt ttaacagtgt     1740

g                                                                     1741


<210>  2
<211>  383
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Gly Val Lys Ala Ser Gln Thr Gly Phe Val Val Leu Val Leu Leu 
1               5                   10                  15      


Gln Cys Cys Ser Ala Tyr Lys Leu Val Cys Tyr Tyr Thr Ser Trp Ser 
            20                  25                  30          


Gln Tyr Arg Glu Gly Asp Gly Ser Cys Phe Pro Asp Ala Leu Asp Arg 
        35                  40                  45              


Phe Leu Cys Thr His Ile Ile Tyr Ser Phe Ala Asn Ile Ser Asn Asp 
    50                  55                  60                  


His Ile Asp Thr Trp Glu Trp Asn Asp Val Thr Leu Tyr Gly Met Leu 
65                  70                  75                  80  


Asn Thr Leu Lys Asn Arg Asn Pro Asn Leu Lys Thr Leu Leu Ser Val 
                85                  90                  95      


Gly Gly Trp Asn Phe Gly Ser Gln Arg Phe Ser Lys Ile Ala Ser Asn 
            100                 105                 110         


Thr Gln Ser Arg Arg Thr Phe Ile Lys Ser Val Pro Pro Phe Leu Arg 
        115                 120                 125             


Thr His Gly Phe Asp Gly Leu Asp Leu Ala Trp Leu Tyr Pro Gly Arg 
    130                 135                 140                 


Arg Asp Lys Gln His Phe Thr Thr Leu Ile Lys Glu Met Lys Ala Glu 
145                 150                 155                 160 


Phe Ile Lys Glu Ala Gln Pro Gly Lys Lys Gln Leu Leu Leu Ser Ala 
                165                 170                 175     


Ala Leu Ser Ala Gly Lys Val Thr Ile Asp Ser Ser Tyr Asp Ile Ala 
            180                 185                 190         


Lys Ile Ser Gln His Leu Asp Phe Ile Ser Ile Met Thr Tyr Asp Phe 
        195                 200                 205             


His Gly Ala Trp Arg Gly Thr Thr Gly His His Ser Pro Leu Phe Arg 
    210                 215                 220                 


Gly Gln Glu Asp Ala Ser Pro Asp Arg Phe Ser Asn Thr Asp Tyr Ala 
225                 230                 235                 240 


Val Gly Tyr Met Leu Arg Leu Gly Ala Pro Ala Ser Lys Leu Val Met 
                245                 250                 255     


Gly Ile Pro Thr Phe Gly Arg Ser Phe Thr Leu Ala Ser Ser Glu Thr 
            260                 265                 270         


Gly Val Gly Ala Pro Ile Ser Gly Pro Gly Ile Pro Gly Arg Phe Thr 
        275                 280                 285             


Lys Glu Ala Gly Thr Leu Ala Tyr Tyr Glu Ile Cys Asp Phe Leu Arg 
    290                 295                 300                 


Gly Ala Thr Val His Arg Thr Leu Gly Gln Gln Val Pro Tyr Ala Thr 
305                 310                 315                 320 


Lys Gly Asn Gln Trp Val Gly Tyr Asp Asp Gln Glu Ser Val Lys Ser 
                325                 330                 335     


Lys Val Gln Tyr Leu Lys Asp Arg Gln Leu Ala Gly Ala Met Val Trp 
            340                 345                 350         


Ala Leu Asp Leu Asp Asp Phe Gln Gly Ser Phe Cys Gly Gln Asp Leu 
        355                 360                 365             


Arg Phe Pro Leu Thr Asn Ala Ile Lys Asp Ala Leu Ala Ala Thr 
    370                 375                 380             


